Victory Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-216,717
| Closed | -$891K | – | 2540 |
|
|
2024
Q1 | $891K | Buy |
216,717
+91,391
| +73% | +$376K | ﹤0.01% | 1794 |
|
|
2023
Q4 | $529K | Sell |
125,326
-21,712
| -15% | -$91.6K | ﹤0.01% | 1982 |
|
|
2023
Q3 | $635K | Sell |
147,038
-3,363
| -2% | -$14.5K | ﹤0.01% | 1879 |
|
|
2023
Q2 | $991K | Sell |
150,401
-85,243
| -36% | -$562K | ﹤0.01% | 1684 |
|
|
2023
Q1 | $1.6M | Sell |
235,644
-43,409
| -16% | -$295K | ﹤0.01% | 1472 |
|
|
2022
Q4 | $2.06M | Sell |
279,053
-13,187
| -5% | -$97.5K | ﹤0.01% | 1426 |
|
|
2022
Q3 | $2.89M | Buy |
292,240
+18,325
| +7% | +$181K | ﹤0.01% | 1371 |
|
|
2022
Q2 | $2.99M | Buy |
273,915
+15,334
| +6% | +$167K | ﹤0.01% | 1360 |
|
|
2022
Q1 | $2.83M | Sell |
258,581
-2,106
| -0.8% | -$23.1K | ﹤0.01% | 1398 |
|
|
2021
Q4 | $4.09M | Buy |
260,687
+5,202
| +2% | +$81.6K | ﹤0.01% | 1377 |
|
|
2021
Q3 | $4.38M | Buy |
255,485
+119,259
| +88% | +$2.04M | ﹤0.01% | 1368 |
|
|
2021
Q2 | $2.93M | Buy |
136,226
+84,772
| +165% | +$1.82M | ﹤0.01% | 1520 |
|
|
2021
Q1 | $773K | Buy |
51,454
+26,585
| +107% | +$399K | ﹤0.01% | 2024 |
|
|
2020
Q4 | $327K | Buy |
24,869
+7,249
| +41% | +$95.3K | ﹤0.01% | 2255 |
|
|
2020
Q3 | $170K | Buy |
+17,620
| New | +$170K | ﹤0.01% | 2304 |
|
|
2020
Q2 | – | Sell |
-14,684
| Closed | -$152K | – | 3278 |
|
|
2020
Q1 | $152K | Buy |
14,684
+4,494
| +44% | +$46.5K | ﹤0.01% | 2404 |
|
|
2019
Q4 | $167K | Buy |
10,190
+2,084
| +26% | +$34.2K | ﹤0.01% | 2364 |
|
|
2019
Q3 | $108K | Buy |
8,106
+5,242
| +183% | +$69.8K | ﹤0.01% | 2412 |
|
|
2019
Q2 | $40K | Sell |
2,864
-4,978
| -63% | -$69.5K | ﹤0.01% | 1760 |
|
|
2019
Q1 | $144K | Buy |
+7,842
| New | +$144K | ﹤0.01% | 1626 |
|